Background: Placebo-controlled trials showed that both benzodiazepines (BDZ) and
antidepressant drugs (AD) are effective in treating anxiety disorders. However, in the last …

Abstract Importance: Benzodiazepines (BZs) are still widely prescribed for the treatment of
anxiety disorders despite many publications in the literature which favour antidepressants …

Long-term benzodiazepines (BZDs) use is not endorsed in the treatment guidelines for
anxiety disorders, but is prevalent in the real-world clinical settings. A systematic literature …

Evaluation of: Martin JLR, Sainz-Pardo M, Furukawa TA et al. Benzodiazepines in
generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and …

Despite current guidelines, benzodiazepines are still considered by many clinicians to
remain good treatment options, in both the acute and the chronic phase of the treatment of …

Benzodiazepines (BDZs) continue to be shrouded in controversy, mainly because of
dependence associated with their long-term use and some of their side effects. Despite …

Objectives and scope: The objective of this article is to briefly review for practicing clinicians
differences among the benzodiazepines (BZDs) that are commonly used to treat anxiety, the …

No systematic review or meta-analysis using a hard outcome has been conducted on the
role of benzodiazepines for generalized anxiety disorder (GAD). The objective of this study …

Introduction: Generalized anxiety disorder (GAD) is a common form of anxiety disorder.
Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake …

Background: The aim of this paper was to perform a systematic review and, when feasible, a
meta-analysis of randomized controlled trials (RCT) which used benzodiazepines (BZD) as …